Pfizer’s CEO Cashed Out 60% Of Its Stock & Unveils the COVID-19 Vaccine Trial On Same Day
Pfizer CEO, Albert Bourla, sold 62% of his stock the same day his experimental COVID-19 vaccine was announced as successful in clinical trials. According to filings registered with the Securities and Exchange Commission, Bourla sold 132,508 shares of the company…
